Trial Profile
LCI-LUN-ABR-001: A Pilot Study of Carboplatin With Nab-Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer of Squamous Histology
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2022
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 26 Dec 2019 Status changed from active, no longer recruiting to completed.
- 19 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Nov 2019.
- 19 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Nov 2019.